aegeline

Other names: aegelin, N-2-hydroxy-2(4-methoxyphenyl) ethyl-3-phenyl-2-propenamide, egeline

Classifications: 6000

Reasons for prohibition: - [{"reason_code": 6019, "reason": "FDA Warning Letter", "link": null, "guid": "1cd0ab89-14ce-43c2-a804-e4b29b8780fe", "link_title": null, "updated": {"_seconds": 1711571477, "_nanoseconds": 43000000}}]

References: - {'title': 'FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported', 'url': 'http://nemsn.org/sites/default/files/PDFs/2-USPlabs-warning%20letter-FDA.pdf'} - {'title': 'NIH NCATS Inxight Drugs entry: Aegeline', 'url': 'https://drugs.ncats.io/drug/60T59LN3SG'}

Reason: FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported

Label terms: []

Searchable name: aegeline

GUID: 0c4a35d7-a541-4fc2-8c5a-4642176f3b69

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1738868732, "_nanoseconds": 4000000}